Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00994942 · ClinicalTrials.gov registry record · NA
Bioequivalency Study of Morphine Sulfate Injection, Solution and Tablet Under Fasted Conditions
A NA study of Pain, sponsored by Roxane Laboratories.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT00994942 is a NA study of Pain that has completed, run by Roxane Laboratories. The registered enrollment target is 18 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00994942, a NA study of Pain, has completed, sponsored by Roxane Laboratories.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
Determine the pharmacokinetics and optimize study design for subsequent studies with morphine sulfate tablets and solution.
Conditions Studied
Interventions
- DRUG morphine sulfate
Study Locations (1)
Texas
- CEDRA Clinical Research - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2006-04 |
| Est. Completion | 2006-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00994942
The ClinicalTrials.gov registry entry for NCT00994942 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (94% lower). The listed sponsor is Roxane Laboratories, which has 93 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 1 intervention - of which morphine sulfate is the first listed.
NCT00994942 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT00994942 about?
NCT00994942 is a clinical study titled "Bioequivalency Study of Morphine Sulfate Injection, Solution and Tablet Under Fasted Conditions". Determine the pharmacokinetics and optimize study design for subsequent studies with morphine sulfate tablets and solution.
What is the current status of trial NCT00994942?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2006-04. Estimated completion is 2006-04.
What conditions does trial NCT00994942 study?
This clinical trial studies the following conditions: Pain.
What interventions are being tested in trial NCT00994942?
The interventions under investigation include: morphine sulfate (DRUG).
Who is sponsoring clinical trial NCT00994942?
This trial is sponsored by Roxane Laboratories, which has 93 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00994942 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Postoperative Pain After Activation of Irrigant
RECRUITING · NA
-
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
RECRUITING · NA
-
Pain With Dementia
RECRUITING · NA
-
Oklahoma Study of Native American Pain Risk IV: Smoking Cessation and Pain
RECRUITING · NA
-
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.